Dispose of your pen, with the needle attached, in a punctureresistant container. You can ask your pharmacist or healthcare provider for information about bydureon bcise that is written for health professionals. Byetta exenatide injection and bydureontm exenatide. Exenatide exenatide extendedrelease storing your pens store your pens in the refrigerator until you use them. Us fda approves new easytouse, onceweekly bydureon. Advise patient that new pen setup should be done only. Before using bydureon bcise, talk to your healthcare provider about how to use it the right way. Bydureon is not a substitute for insulin and has not been studied in combination with insulin. The european medicines agency noted that the benefits of bydureon, such as its effect on reducing the levels of hba1c, compare well with those of comparator medicines and that its side effects are manageable. The new autoinjector features a simpler mixing process, a hidden needle, and a viewing window for users to confirm that theyve received the medication. The agency therefore decided that bydureon s benefits are greater than its risks and recommended that it be given marketing authorisation.
This medication helps your pancreas produce insulin more efficiently. Type 2 diabetes drug bydureon gets a makeover goodrx. Bydureon pen is a onceweekly, singledose, prefilled pen with no titration. Bydureon pen should be trained on proper mixing and injection. The original bydureon singledose tray remains available for current and new patients. Bydureon exenatide extendedrelease and bydureon bcise may cause serious side effects, including. Bydureon prices, coupons and patient assistance programs. This drug has four hundred and seventysix patent family members in fortyseven countries. Check our savings tips for copay cards, assistance programs, and other ways to reduce your cost. Medication guide bydureon bydureeon for injectable. The main differences between the old bydureon pen and the new bydureon bcise are as follows. Bydureon 2 mg powder and solvent for prolongedrelease suspension for injection in prefilled pen. Bydureon bcise causes thyroid ccell tumors, including medullary thyroid carcinoma mtc in humans, as the human relevance of exenatide extendedreleaseinduced rodent thyroid ccell tumors has not been determined. Fda approves bydureon bcise new autoinjector to launch.
Bydureon is provided in a pen injector consisting of a dual. Though it isnt insulin, it is injected in a similar way. Possible thyroid tumors, including cancer tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. Roni shye, pharmd bcgp bcacp, is a licensed pharmacist in the states of florida, ohio, and pennsylvania. After mixing, check the window to see if the medicine is cloudy with no clumps. Bydureon may cause serious side effects, including. Each singledose pen contains 2 mg of exenatide and diluent, and includes one needle. The recommended dose of bydureon is 2 mg subcutaneously once every 7 days weekly. Read the instructions for use before you start using bydureon bcise. The day of weekly administration can be changed if necessary as long as the last dose was administered 3 or more days before the new day of administration. Do not use bydureon after the expiration date printed on the product packaging carton and pen injector. Bydureon is a glp1 analogue, the first weekly treatment for type 2 diabetes. The bydureon pen contains the same formulation and dose as the original bydureon singledose tray, providing the same continuous release of exenatide. Learn more about bydureon bcise, an enhanced formulation in a simplified device.
Capitals indicate lifethreatening, underlines indicate most frequent. Bydureon medicare coverage and copay details goodrx. Bydureon singledose tray which contains one vial of 2 mg exenatide, one vial connector, one prefilled diluent syringe, and two needles one provided as a spare. Bydureon exenatide extendedrelease for injectable suspension. This bydureon price guide is based on using the drugs. Chinese, simplified mandarin dialect bilingual pdf. Read the user manual for information on how to use the bydureon kit, pen or autoinjector before use. To use the pen, set the needle on top and turn the knob on the. Bcise for a condition for which it was not prescribed. Bydureon is the first onceweekly treatment option for adults with type 2 diabetes, and bydureon pen now offers the same continuous release of exenatide in a prefilled device, said john yee, m.
Singledose pen which contains 2 mg of exenatide white to offwhite powder, diluent, and. Bydureon is a longacting form of the medication in byetta exenatide injection so both drugs should not be used together. Astrazeneca launches the new bydureon pen in the us diatribe. We also recommend that you view the video below before using the bydureon pen. Information for the user bydureon 2 mg powder and solvent for prolongedrelease suspension for injection in prefilled pen exenatide read all of this leaflet carefully before you start using this medicine because it contains important information for you. Us fda approves new easytouse, onceweekly bydureon bcise injectable medicine for patients with type2 diabetes.
If a dose is missed, administer the dose as soon as noticed, provided the next regularly scheduled dose is. Bydureon pen is designed to be patientfriendly and can be used any time of day, with or without meals. How to use bydureon bcise bydureon bcise exenatide. The fda recently approved a new pen form of diabetes injection bydureon exenatide, which is gaining popularity and causing mixups at the pharmacy the existing bydureon vial and the new pen contain the same medication, but the two forms are not interchangeableyour pharmacist will need to fill the form your doctor has prescribed. A bydureon pen is a userfriendly way to lower blood sugar in people with type 2 diabetes. The dose can be administered at any time of day, with or without meals. The recommended dose of bydureon bcise is 2 mg subcutaneously once every 7 days weekly. For subcutaneous use only singledose autoinjector once weekly. Read the user manual each time you get a new kit or pen, in case something has changed. Your doctor has most likely explained about your new treatment plan, but when starting a new.
It was previously available only in the kit with syringe. The design of the new device incorporates user and healthcare provider feedback on the previous bydureon dualchambered pen. Bydureon bcise has a unique, continuousrelease microsphere delivery system designed to provide consistent therapeutic levels of exenatide. The new bydureon device is a prefilled, singleuse pen injector, which eliminates the need for the user to transfer the medication between a vial and syringe during the selfinjection process and reduces some of the hassle factor of taking bydureon. Home conditions diabetes type 2 diabetes drug bydureon gets a makeover. Please click here for medication guide, and click here for full prescribing information for bydureon pen.
Take out one pen and let it sit at room temperature for at least 15 minutes. Bydureon is covered by some medicare and insurance plans. Bydureon exenatide is a member of the incretin mimetics drug class and is commonly used for diabetes type 2. Most peoplein fact 85% who were part of a studyagreed that onceweekly bydureon bcise is easy or very easy to use its a noninsulin medicine in an injectable device holding just one dose. Your 1st injection bydureon exenatide extendedrelease for. This medication guide provides information about the bydureon brand of exenatide. Im not a fan of bydureon because it has statistically less a1c lowering compared to once daily victoza duration6 trial. Refer to the user manual each time you inject this medicine. The bydureon pen is a prefilled, singleuse pen injector, eliminating the need for the patient to transfer the medication between a vial and syringe during the selfinjection process. Bydureon is not recommended as the first medication to treat diabetes.
Dr eggitt explains how to use the new bydureon pen device the oakwood surgery, doncaster uk. Bydureon bcise is expected to launch in early 2018. You can keep a pen at room temperature for 28 days. Bydureon is currently available as a pen and a singledose tray formulation, both which require assembly. New bydureon pen for diabetes now available goodrx. New formulation of onceweekly exenatide in an improved device provides significant hba1c reduction with added benefit of weight loss. Bydureon exenatide extendedrelease for injectable suspension is available as.
Byetta is another brand of exenatide that is not covered in this medication guide bydureon pen is an injectable diabetes medicine that helps control blood sugar levels. Bydureon bcise is a onceweekly, noninsulin prescription medicine used along with diet and exercise to help improve blood sugar in adults with type 2 diabetes. Bydureon bcise autoinjector must be injected immediately after mixing the suspension. When do bydureon patents expire, and what generic alternatives are available. Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes. The bydureon pen requires the needle to be assembled to the pen and the single dose tray requires assembly of the syringe, vial and vial. Goodrx has partnered with inside rx and astrazeneca to reduce the price for this prescription. Please refer to your supplemental new drug application snda dated august 29, 20. Bydureon is a drug marketed by astrazeneca ab and is included in two ndas. Learn how to use bydureon bcise exenatide extendedrelease. Bydureon 2 mg powder and solvent for prolongedrelease suspension for injection in prefilled pen how to use bydureon prefilled pen cover knob orange label striped label needle top of pen mixing window inspection window green label prior to use of the pen, it is recommended that you should be trained by a doctor or diabetes nurse on its proper.
172 1228 272 1617 245 1542 79 1214 583 1251 308 188 159 880 31 1458 1518 88 531 668 1232 1129 1344 455 740 1008 1335 76 1479 503 871 813 578 70 1175